Navvisa is carving a niche in the intersection of Digital Health, Health Care, and Human Resources with its innovative approach to cancer care. Founded in 2021 and headquartered in the United States, the company aims to transform the cancer treatment landscape by offering personalized guidance through partnerships with employee benefit programs.
By leveraging expert oncology nurses, Navvisa provides tailored support to those impacted by a cancer diagnosis—including patients, caregivers, and survivors. The company's services aim to help clients navigate understanding diagnoses, attending medical appointments, managing symptoms, and overcoming barriers to receiving care. Importantly, the focus extends to reducing time away from work, adding a compelling value proposition for employers and employees alike.
To date, Navvisa has not disclosed any recent investments, signaling potential opportunities for early backers. Investors with an interest in health tech startups may find Navvisa a promising candidate for its dedication to innovating employee healthcare support.